Athena Pharmaceutiques Oral Dispersible Tablets

Athena Pharmaceutiques Oral Dispersible Tablets

X

Digital content for Carmell Therapeutics

Carmell Therapeutics

CARMELL THERAPEUTICS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

8 News

8 News

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

Full View Screen

Full Screen View

Carmell Therapeutics plans SPAC deal with Alpha Healthcare, bypassing IPO

Carmell Therapeutics plans SPAC deal with Alpha Healthcare, bypassing IPO

Katherine Lewin ENDPTS

05 Jan 2023

Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell

Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell

BUSINESSWIRE

04 Jan 2023

Carmell Gains Alignment with FDA to Evaluate the Use of Its Lead Product

Carmell Gains Alignment with FDA to Evaluate the Use of Its Lead Product

BUSINESSWIRE

17 Nov 2022

Carmell Announces Submission of Registration Statement for Public Listing

Carmell Announces Submission of Registration Statement for Public Listing

BUSINESSWIRE

07 Sep 2022

Carmell Therapeutics Appoints Sebastian “Sebby” Borriello to CBO

Carmell Therapeutics Appoints Sebastian “Sebby” Borriello to CBO

BUSINESSWIRE

11 May 2022

Carmell Therapeutics Announces Appointment of Dr. Israel Nur Scientific Advisor

Carmell Therapeutics Announces Appointment of Dr. Israel Nur Scientific Advisor

BUSINESSWIRE

07 Oct 2020

FDA grants Carmell Therapeutics Expedited Review for CT-101

FDA grants Carmell Therapeutics Expedited Review for CT-101

BUSINESSWIRE

27 Apr 2020

FDA grants Carmell Therapeutics Expedited Review for CT-101, Accelerant

FDA grants Carmell Therapeutics Expedited Review for CT-101, Accelerant

BUSINESSWIRE

27 Apr 2020

laboratorium-ofichem-b-v-m-2023-03-20

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search